D-0490-2019 Class III Terminated

Recalled by Valeant Pharmaceuticals North America LLC — Bridgewater, NJ

Recall Details

Product Type
Drugs
Report Date
February 20, 2019
Initiation Date
January 30, 2019
Termination Date
July 8, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22 bottles

Product Description

Cardizem CD (diltiazem HCl) capsules, 300 mg, packaged in a) 30-count bottles (NDC 0187-0798-30); and b) 90-count bottles (NDC 0187-0798-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.

Reason for Recall

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Distribution Pattern

Nationwide in the USA and Puerto Rico

Code Information

Lots: a)18J020P, Exp 08/2020; b) 18J034P, Exp 08/2020